Semaglutide (Wegovy) in Dalton, GA.

The medicine and its names

Semaglutide and its brand names.

Wegovy, Ozempic and Rybelsus are all semaglutide, sold under different brand names for different approved uses.

Wegovy is FDA-approved. At Limitless it is part of the physician-led weight-loss program that Dr. Hare designs and monitors. That program’s four pillars apply whether a patient takes semaglutide, tirzepatide or no drug at all; the medical weight loss page lays them out.

Still deciding

If you are still comparing medicines.

At Limitless the choice of drug rests on your lab results, any other conditions you have and what you want from treatment. A history of heart disease is one of the factors weighed. You do not need to have picked a medicine before you request a consultation.

For the evidence, the tirzepatide vs. semaglutide page covers the head-to-head trial, side effects, heart outcomes and how Limitless picks between the two. For eligibility, see if you count as a candidate for GLP-1 therapy: that guide sets out the FDA criteria, the screening labs and the patients Limitless declines to prescribe for. If you have already settled on tirzepatide, read about tirzepatide care in Dalton.

What to ask Dr. Hare if you are undecided

What rules semaglutide out

Limitless declines to prescribe semaglutide to anyone whose personal or family history includes medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia type 2 (MEN 2). That is the history semaglutide’s boxed warning covers, and Limitless screens for it at intake. Limitless also declines to prescribe semaglutide when there is active or recent pancreatitis, severe gastroparesis, an active eating disorder, or pregnancy, planned pregnancy or breastfeeding. The guide to who counts as a candidate for GLP-1 therapy has the full list.

Injection and tablets

The weekly injection, and questions about tablets.

Injectable semaglutide is given once a week under the skin, and Limitless trains you in the clinic to give it yourself.

If injecting is what gives you pause, say so to Dr. Hare at your consultation. For background on how semaglutide tablets compare with the injections, see the 2026 GLP-1 landscape.

Already on semaglutide

Already taking semaglutide elsewhere.

If you take semaglutide now, you may want to stay on it under a new clinician, or change to a different medicine.

Keeping semaglutide, with Limitless as your new clinician

Limitless handles that kind of transfer of care routinely: it obtains your prior records and redoes your baseline labs, and no GLP-1 prescription goes out without that baseline panel. Whether you stay on semaglutide depends on those labs and your history. If the semaglutide you take now is Ozempic (the type 2 diabetes brand) or a compounded version, tell Dr. Hare at your consultation. Moving GLP-1 care to Limitless explains the rest of a transfer.

Changing from semaglutide to tirzepatide

Limitless can switch you from semaglutide to tirzepatide if your labs and history support the change; the frequently asked questions on tirzepatide vs. semaglutide explain how.

Cost

Who you pay, and for what.

You pay a pharmacy for the medicine itself. You pay Limitless for the clinical management of your care, as a membership or per visit. Insurance does not pay for that part. Limitless gives you its quote during the consultation, and the request form takes no payment.

Cost, insurance and payment sets out both charges for weight care in full, including what affects the pharmacy bill.

Visiting the clinic

Your first visit, in Dalton.